Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 ...
Zacks Investment Research on MSN1h
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...
ALEX Neil was disappointed to have to make early substitutions during Millwall's 2-0 loss to Leeds United on Wednesday, and ...
StockNews.com started coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report released on Thursday. The firm issued a buy rating on the biotechnology company’s ...
Ali Al-Hamadi's return to scoring form against Blackburn Rovers could provide a huge boost to both loan side Stoke City, as ...
Equities research analysts at Lifesci Capital issued their Q1 2025 earnings estimates for Tenaya Therapeutics in a report issued on Tuesday, March 11th. Lifesci Capital analyst C. Jubinville expects ...
Do you want coverage of the enemies of freedom you can't get from the mainstream media?
HB 470 would expand the "Capitol Complex," giving the Texas Department of Public Safety jurisdiction over 18 blocks around ...
Stoke City goalkeeper Viktor Johansson has been praised by manager Mark Robins for the way he bounced back from a difficult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback